Giuffre Randall Michael
SEC insider (Form 3/4/5 filer). CIK 0001759822. Director at DiaMedica Therapeutics Inc. (DMAC). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in MINNEAPOLIS, MN.
Companies Giuffre Randall Michael has filed insider reports for
- DiaMedica Therapeutics Inc. (DMAC): Director
Giuffre Randall Michael
CIK: 0001759822
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DiaMedica Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 1, 2026DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
40.4K shares- - Jan 2, 2026DMAC
DiaMedica Therapeutics Inc.
AwardDirect6.2K shares at avg. $8.42$52K - Jun 1, 2025DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
32.2K shares- - Feb 13, 2025DMAC
DiaMedica Therapeutics Inc.
ExerciseDirect12K shares at avg. $2.11$25K - Feb 13, 2025DMAC
DiaMedica Therapeutics Inc.
ExerciseDirect5K shares at avg. $3.65$18K - Jan 2, 2025DMAC
DiaMedica Therapeutics Inc.
AwardDirect10.9K shares at avg. $5.34$58K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 | DMAC DiaMedica Therapeutics Inc. | Award Stock Option (right to buy) | 40,412 | - | - | Direct |
| Jan 2, 2026 | DMAC DiaMedica Therapeutics Inc. | Award | 6,175 | $8.42 | $51,994 | Direct |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | Award Stock Option (right to buy) | 32,162 | - | - | Direct |
| Feb 13, 2025 | DMAC DiaMedica Therapeutics Inc. | Exercise | 12,000 | $2.11 | $25,320 | Direct |
| Feb 13, 2025 | DMAC DiaMedica Therapeutics Inc. | Exercise | 5,000 | $3.65 | $18,250 | Direct |
| Jan 2, 2025 | DMAC DiaMedica Therapeutics Inc. | Award | 10,861 | $5.34 | $57,998 | Direct |
1-6 of 6 transactions